CDKN2A and cancer: However, these CRC cells also contain mutations in other cancer related genes (HCT116: KRAS, PIK3CA, CTNNB1, BRCA2, CDKN2A etc.; SW480 or SW620: KRAS and APC etc.)[47], which constitute a unique pathological context in every CRC cell.